Treatment of a solid tumor using engineered drug-resistant immunocompetent cells and cytotoxic chemotherapy.
about
Immunological and Translational Aspects of NK Cell-Based Antitumor ImmunotherapiesEngineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapyRetrospective comparative study of the effects of dendritic cell vaccine and cytokine-induced killer cell immunotherapy with that of chemotherapy alone and in combination for colorectal cancer.A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy.Dual Functional Capability of Dendritic Cells - Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer TherapyCo-culture with NK-92MI cells enhanced the anti-cancer effect of bee venom on NSCLC cells by inactivation of NF-κB.
P2860
Treatment of a solid tumor using engineered drug-resistant immunocompetent cells and cytotoxic chemotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Treatment of a solid tumor usi ...... ls and cytotoxic chemotherapy.
@ast
Treatment of a solid tumor usi ...... ls and cytotoxic chemotherapy.
@en
type
label
Treatment of a solid tumor usi ...... ls and cytotoxic chemotherapy.
@ast
Treatment of a solid tumor usi ...... ls and cytotoxic chemotherapy.
@en
prefLabel
Treatment of a solid tumor usi ...... ls and cytotoxic chemotherapy.
@ast
Treatment of a solid tumor usi ...... ls and cytotoxic chemotherapy.
@en
P2093
P2860
P356
P1433
P1476
Treatment of a solid tumor usi ...... ls and cytotoxic chemotherapy.
@en
P2093
Anindya Dasgupta
H Trent Spencer
Jordan E Shields
P2860
P304
P356
10.1089/HUM.2011.172
P577
2012-04-18T00:00:00Z